(Q54539761)

31 May 2018

title

Diagnostic use of nuclear beta-catenin expression for the assessment of endometrial stromal tumors. (English)

1 reference

31 May 2018

author name string

Chan-Kwon Jung

1

1 reference

31 May 2018

Ji-Han Jung

2

1 reference

31 May 2018

Ahwon Lee

3

1 reference

31 May 2018

Youn-Soo Lee

4

1 reference

31 May 2018

Yeong-Jin Choi

5

1 reference

31 May 2018

Seung-Kew Yoon

6

1 reference

31 May 2018

Kyo-Young Lee

7

1 reference

31 May 2018

publication date

28 March 2008

1 reference

31 May 2018

published in

Modern Pathology

1 reference

31 May 2018

volume

21

1 reference

31 May 2018

issue

6

1 reference

31 May 2018

page(s)

756-763

1 reference

31 May 2018

https://scigraph.springernature.com/pub.10.1038/modpathol.2008.53

exact match

0 references

cites work

Cytoplasmic and/or nuclear accumulation of the beta-catenin protein is a frequent event in human osteosarcoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.53

Nuclear beta-catenin expression distinguishes deep fibromatosis from other benign and malignant fibroblastic and myofibroblastic lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.53

Beta-catenin immunohistochemistry separates mesenteric fibromatosis from gastrointestinal stromal tumor and sclerosing mesenteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.53

Inverse correlation of secreted frizzled-related protein 4 and beta-catenin expression in endometrial stromal sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.53

Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.53

CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.53

Endometrial stromal sarcoma expression of estrogen receptors, progesterone receptors and estrogen-induced srp27 (24K) suggests hormone responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.53

A common human skin tumour is caused by activating mutations in beta-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.53

Nuclear beta-catenin in mesenchymal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.53

7 January 2021

CD10 is a marker for normal and neoplastic endometrial stromal cells

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.53

7 January 2021

Frequent nuclear beta-catenin accumulation and associated mutations in endometrioid-type endometrial and ovarian carcinomas with squamous differentiation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.53

7 January 2021

An immunohistochemical study of normal endometrial stroma and endometrial stromal neoplasms. Evidence for smooth muscle differentiation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.53

7 January 2021

Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor)

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.53

7 January 2021

10.1038/MODPATHOL.2008.53

Identifiers

DOI

1 reference

31 May 2018

1 reference

31 May 2018